Trilogy Capital’s Travelers Companies TRV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$253K Sell
710
-145
-17% -$53.1K 0.01% 368
2026
Q2
$282K Sell
855
-163
-16% -$49.4K 0.01% 339
2026
Q1
$297K Buy
1,018
+32
+3% +$9.37K 0.01% 322
2025
Q4
$286K Buy
+986
New +$278K 0.01% 321
2018
Q4
– Sell
-269
Closed -$35K – 523
2018
Q3
$35K Buy
269
+12
+5% +$1.55K ﹤0.01% 223
2018
Q2
$31K Hold
257
– – ﹤0.01% 220
2018
Q1
$36K Buy
+257
New +$35.9K 0.01% 185

Other funds holding TRV

Trilogy Capital's TRV Position: Q3 2026 in Review

Trilogy Capital reduced its Travelers Companies (TRV) stake by 17% in Q3 2026, selling an estimated $53.1K and leaving 710 shares worth $253K. The position accounts for 0.01% of the portfolio, ranked #368.

Trilogy Capital first reported a position in TRV in Q1 2018 and has held it in 7 quarters since. The position peaked at $297K in Q1 2026. 790 funds tracked by Wall St. Rank hold TRV as of Q3 2026.

  • Trilogy Capital held 710 shares of Travelers Companies worth $253K as of Q3 2026.
  • Trilogy Capital sold 145 Travelers Companies shares in Q3 2026, an estimated $53.1K.
  • Travelers Companies made up 0.01% of Trilogy Capital's portfolio in Q3 2026, its #368 holding.
  • Trilogy Capital first reported a position in Travelers Companies in Q1 2018 and has held it in 7 quarters since.
  • Trilogy Capital's Travelers Companies position peaked at $297K in Q1 2026.
  • 790 funds tracked by Wall St. Rank held Travelers Companies as of Q3 2026.

Based on Trilogy Capital's 13F filing for Q3 2026, filed 20 Oct 2026.